July 2021 updates to the website
14 July 2021
The website has now been updated following July's LSCMMG
The following guidelines have been added/updated:
Trans female gender dysphoria information sheet - Updated
The following medicines have been added/updated:
Budesonide orodispersible tablet (NICE TA708) - For inducing remission of eosinophilic oesophagitis
Guselkumab (NICE TA711) - For treating active psoriatic arthritis after inadequate response to DMARDs
The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:
Sodium oxybate - Narcolepsy with cataplexy
Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (Sativex®) - For symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication